AbbVie Inc. officer Timothy Richmond is set to sell 75,680 common shares of the company, with an aggregate market value of approximately $13.38 million, on March 1, 2024. The shares to be sold were recently acquired through stock option exercises and performance shares. Specifically, Richmond acquired 45,700 shares on March 1, 2024, through stock option exercise, paying with cash, and 29,980 shares on February 28, 2024, as performance shares from the issuer. There is no recent sale history reported for the past three months. The notice for the planned sale was filed on the same day as the sale, with the plan for this transaction having been adopted on November 13, 2023.

AbbVie Inc. officer Timothy Richmond is set to sell 75,680 common shares of the company, with an aggregate market value of approximately $13.38 million, on March 1, 2024. The shares to be sold were recently acquired through stock option exercises and performance shares. Specifically, Richmond acquired 45,700 shares on March 1, 2024, through stock option exercise, paying with cash, and 29,980 shares on February 28, 2024, as performance shares from the issuer. There is no recent sale history reported for the past three months. The notice for the planned sale was filed on the same day as the sale, with the plan for this transaction having been adopted on November 13, 2023.